Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Q2 EBITDA at SEK -4.15 Million

Apr 10 (Reuters) - Newbury Pharmaceuticals Q2 EBITDA SEK -4.147 million.
* Q2 operating cash flow SEK -7.98 million
* Q2 revenue SEK 3.135 million

Recent news on Newbury Pharmaceuticals AB

See all news